A single-arm phase II trial of gemcitabine, oxaliplatin, and panitumumab in KRAS wild-type advanced biliary tract cancer.

Authors

null

Marcus Smith Noel

University of Rochester, Rochester, NY

Marcus Smith Noel , Jill N. Allen , Thomas Adam Abrams , Matthew Yurgelun , Jason Edward Faris , Lipika Goyal , Jeffrey W. Clark , Lawrence Scott Blaszkowsky , Janet E. Murphy , Hui Zheng , Alok A. Khorana , Gregory Clayton Connolly , Ollivier Hyrien , Kimmie Ng , Darrell R. Borger , Anthony John Iafrate , Aram F. Hezel , Andrew X. Zhu

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

NCT01308840

Citation

J Clin Oncol 32, 2014 (suppl 3; abstr 255)

DOI

10.1200/jco.2014.32.3_suppl.255

Abstract #

255

Poster Bd #

B28

Abstract Disclosures